Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients".
作者信息
Floyd James S, Psaty Bruce M
机构信息
Cardiovascular Health Research Unit, University of Washington, Seattle, 98101, USA.
出版信息
Arch Intern Med. 2012 Oct 8;172(18):1412-14. doi: 10.1001/archinternmed.2012.4306.
Abstract
摘要
相似文献
1
Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients".
Arch Intern Med. 2012 Oct 8;172(18):1412-14. doi: 10.1001/archinternmed.2012.4306.
2
Comparative effectiveness of 2 β-blockers in hypertensive patients.
Arch Intern Med. 2012 Oct 8;172(18):1406-12. doi: 10.1001/archinternmed.2012.4276.
3
Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Am J Ther. 2017 Jan/Feb;24(1):e68-e80. doi: 10.1097/MJT.0000000000000369.
4
The case for beta-blockers as first-line antihypertensive therapy.
J Hypertens Suppl. 1992 Jun;10(3):S21-7.
5
Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular events.
Clin Cornerstone. 2004;6(4):18-27. doi: 10.1016/s1098-3597(04)80075-9.
6
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
Eur J Hum Genet. 2007 Apr;15(4):478-84. doi: 10.1038/sj.ejhg.5201789. Epub 2007 Feb 14.
7
The Role of Beta-Blockers in the Treatment of Hypertension.
Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36.
8
beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Am J Hypertens. 2008 Mar;21(3):290-6. doi: 10.1038/ajh.2007.71. Epub 2008 Jan 24.
9
Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
J Am Coll Cardiol. 2008 Oct 28;52(18):1482-9. doi: 10.1016/j.jacc.2008.06.048.
10
Beta-blockers in hypertensive and coronary heart disease.
Arch Intern Med. 1996 Jun 24;156(12):1267-76.
本文引用的文献
1
Comparative effectiveness of 2 β-blockers in hypertensive patients.
Arch Intern Med. 2012 Oct 8;172(18):1406-12. doi: 10.1001/archinternmed.2012.4276.
2
The evolving role of β-adrenergic receptor blockers in managing hypertension.
Can J Cardiol. 2012 May;28(3):334-40. doi: 10.1016/j.cjca.2012.04.001.
3
Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.
Hypertension. 2012 Jun;59(6):1110-7. doi: 10.1161/HYPERTENSIONAHA.112.191106. Epub 2012 Apr 23.
4
When should we believe nonrandomized studies of comparative effectiveness?
Clin Pharmacol Ther. 2011 Dec;90(6):764-6. doi: 10.1038/clpt.2011.243.
5
Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction.
JAMA. 2010 Aug 25;304(8):897-8. doi: 10.1001/jama.2010.1205.
6
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Ann Intern Med. 2009 Jun 2;150(11):784-94. doi: 10.7326/0003-4819-150-11-200906020-00006.
7
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.
8
Beta-blockers for hypertension.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD002003. doi: 10.1002/14651858.CD002003.pub2.
9
Recent trials in hypertension: compelling science or commercial speech?
JAMA. 2006 Apr 12;295(14):1704-6. doi: 10.1001/jama.295.14.1704.
10
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lancet. 2005;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3.
Zotero 插件